Advent To Buy Suven Pharma In A Rs 9,589-Crore Deal

  • last year
Global private equity firm Advent International will acquire a 50.1% stake in Suven Pharma, buying 12.75 crore shares for a total of Rs 6,313 crore. Suven Pharma MD Venkateswarlu Jasti discusses the acquisition.

Recommended